Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

The Orphan Drug Act: An Appropriate Approval Pathway for Treatments of Rare Diseases?

Gabay M.

Hosp Pharm. 2019 Oct;54(5):283-284. doi: 10.1177/0018578719867665. Epub 2019 Aug 2.

PMID:
31555002
2.

Mapping spin-charge conversion to the band structure in a topological oxide two-dimensional electron gas.

Vaz DC, Noël P, Johansson A, Göbel B, Bruno FY, Singh G, McKeown-Walker S, Trier F, Vicente-Arche LM, Sander A, Valencia S, Bruneel P, Vivek M, Gabay M, Bergeal N, Baumberger F, Okuno H, Barthélémy A, Fert A, Vila L, Mertig I, Attané JP, Bibes M.

Nat Mater. 2019 Sep 9. doi: 10.1038/s41563-019-0467-4. [Epub ahead of print]

PMID:
31501554
3.

Dispersion-box modeling investigation of the influences of gasoline, diesel, M85 and E85 vehicle exhaust emission on photochemistry.

Gabay M, Tas E.

Environ Pollut. 2019 Sep;252(Pt B):1863-1871. doi: 10.1016/j.envpol.2019.05.142. Epub 2019 Jun 8.

PMID:
31369942
4.

Effects of Cigarette Smoke on TSPO-related Mitochondrial Processes.

Zeineh N, Nagler R, Gabay M, Weizman A, Gavish M.

Cells. 2019 Jul 10;8(7). pii: E694. doi: 10.3390/cells8070694.

5.

Bimodal Phase Diagram of the Superfluid Density in LaAlO_{3}/SrTiO_{3} Revealed by an Interfacial Waveguide Resonator.

Manca N, Bothner D, Monteiro AMRVL, Davidovikj D, Sağlam YG, Jenkins M, Gabay M, Steele GA, Caviglia AD.

Phys Rev Lett. 2019 Jan 25;122(3):036801. doi: 10.1103/PhysRevLett.122.036801.

PMID:
30735404
6.

Managing the Aesthetic Patient

Haddad A, Meski APG, Cazerta C, Guarnieri C, Palermo E, Sarubi J, Lourenço L, Avelar LE, Morais MH, Gabay MA, Parada MB, Ferraz R, Maia R, Shitara D.

J Drugs Dermatol. 2019 Jan 1;18(1):92-102.

PMID:
30681806
7.

Investigation of ozone deposition to vegetation under warm and dry conditions near the Eastern Mediterranean coast.

Li Q, Gabay M, Rubin Y, Raveh-Rubin S, Rohatyn S, Tatarinov F, Rotenberg E, Ramati E, Dicken U, Preisler Y, Fredj E, Yakir D, Tas E.

Sci Total Environ. 2019 Mar 25;658:1316-1333. doi: 10.1016/j.scitotenv.2018.12.272. Epub 2018 Dec 19.

PMID:
30677993
8.

RxLegal: Pharmacist Gag Clauses.

Gabay M.

Hosp Pharm. 2018 Dec;53(6):376-377. doi: 10.1177/0018578718802833. Epub 2018 Sep 22.

PMID:
30559523
9.

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma.

Lai I, Swaminathan S, Baylot V, Mosley A, Dhanasekaran R, Gabay M, Felsher DW.

J Immunother Cancer. 2018 Nov 20;6(1):125. doi: 10.1186/s40425-018-0431-x.

10.

Measurement-based investigation of ozone deposition to vegetation under the effects of coastal and photochemical air pollution in the Eastern Mediterranean.

Li Q, Gabay M, Rubin Y, Fredj E, Tas E.

Sci Total Environ. 2018 Dec 15;645:1579-1597. doi: 10.1016/j.scitotenv.2018.07.037. Epub 2018 Jul 25.

PMID:
30248876
11.

Intravenous Push Administration of Antibiotics: Literature and Considerations.

Spencer S, Ipema H, Hartke P, Krueger C, Rodriguez R, Gross AE, Gabay M.

Hosp Pharm. 2018 Jun;53(3):157-169. doi: 10.1177/0018578718760257. Epub 2018 Mar 8.

12.

A spin-orbit playground: surfaces and interfaces of transition metal oxides.

Gariglio S, Caviglia AD, Triscone JM, Gabay M.

Rep Prog Phys. 2019 Jan;82(1):012501. doi: 10.1088/1361-6633/aad6ab. Epub 2018 Jul 30.

PMID:
30058557
13.

RxLegal: A Rapid Review of Right-To-Try.

Gabay M.

Hosp Pharm. 2018 Jul;53(4):234-235. doi: 10.1177/0018578718783992. Epub 2018 Jun 20.

14.

Dual phosphorylation of Ric-8A enhances its ability to mediate G protein α subunit folding and to stimulate guanine nucleotide exchange.

Papasergi-Scott MM, Stoveken HM, MacConnachie L, Chan PY, Gabay M, Wong D, Freeman RS, Beg AA, Tall GG.

Sci Signal. 2018 May 29;11(532). pii: eaap8113. doi: 10.1126/scisignal.aap8113.

15.

The Prescription Drug User Fee Act: Cause for Concern?

Gabay M.

Hosp Pharm. 2018 Apr;53(2):88-89. doi: 10.1177/0018578718757519. Epub 2018 Feb 12.

16.

Spin-Orbit Semimetal SrIrO_{3} in the Two-Dimensional Limit.

Groenendijk DJ, Autieri C, Girovsky J, Martinez-Velarte MC, Manca N, Mattoni G, Monteiro AMRVL, Gauquelin N, Verbeeck J, Otte AF, Gabay M, Picozzi S, Caviglia AD.

Phys Rev Lett. 2017 Dec 22;119(25):256403. doi: 10.1103/PhysRevLett.119.256403. Epub 2017 Dec 22.

PMID:
29303305
17.

Biosimilar Substitution Laws.

Gabay M.

Hosp Pharm. 2017 Sep;52(8):544-545. doi: 10.1177/0018578717726995. Epub 2017 Aug 22. No abstract available.

18.

The Evolution of Drug Information Centers and Specialists.

Gabay MP.

Hosp Pharm. 2017 Jul;52(7):452-453. doi: 10.1177/0018578717724235. Epub 2017 Aug 3. No abstract available.

19.

Direct and Indirect Remuneration Fees: The Controversy Continues.

Gabay M.

Hosp Pharm. 2017 Dec;52(11):740-741. doi: 10.1177/0018578717739633. Epub 2017 Nov 9.

20.

21st Century Cures Act.

Gabay M.

Hosp Pharm. 2017 Apr;52(4):264-265. doi: 10.1310/hpj5204-264. No abstract available.

21.

White Paper on Natural Products.

Gabay M, Smith JA, Chavez ML, Goldwire M, Walker S, Coon SA, Gosser R, Hume AL, Musselman M, Phillips J, Abe AM.

Pharmacotherapy. 2017 Jan;37(1):e1-e15. doi: 10.1002/phar.1874. Epub 2016 Dec 9.

PMID:
27943330
22.

Increasing Access to Naloxone and Legal Issues.

Gabay M.

Hosp Pharm. 2016 Sep;51(8):633-634. No abstract available.

23.

Magnetism, Spin Texture, and In-Gap States: Atomic Specialization at the Surface of Oxygen-Deficient SrTiO_{3}.

Altmeyer M, Jeschke HO, Hijano-Cubelos O, Martins C, Lechermann F, Koepernik K, Santander-Syro AF, Rozenberg MJ, Valentí R, Gabay M.

Phys Rev Lett. 2016 Apr 15;116(15):157203. doi: 10.1103/PhysRevLett.116.157203. Epub 2016 Apr 14.

PMID:
27127984
24.

Regulation of Internet Pharmacies: A Continuing Challenge.

Gabay M.

Hosp Pharm. 2015 Sep;50(8):681-2. doi: 10.1310/hpj5008-681. Epub 2015 Sep 16. No abstract available.

25.

Oral Targeted Therapies and Central Nervous System (CNS) Metastases.

Gabay MP, Wirth SM, Stachnik JM, Overley CL, Long KE, Bressler LR, Villano JL.

CNS Drugs. 2015 Nov;29(11):935-52. doi: 10.1007/s40263-015-0283-6. Review.

PMID:
26563196
26.

Observational Evidence for Involvement of Nitrate Radicals in Nighttime Oxidation of Mercury.

Peleg M, Tas E, Obrist D, Matveev V, Moore C, Gabay M, Luria M.

Environ Sci Technol. 2015 Dec 15;49(24):14008-18. doi: 10.1021/acs.est.5b03894. Epub 2015 Nov 30.

PMID:
26551088
27.

Analgesic and Anti-Inflammatory Properties of Arylnitroalkenes.

Celano L, Cupertino Da Silva YK, Cataldo N, Gabay M, Merlino A, Alexandre-Moreira MS, Lima LM, Cerecetto H, González M, Thomson L.

Inflamm Allergy Drug Targets. 2015;14(1):19-28.

PMID:
26490661
28.

Providing Feedback to Colleagues: A Continual Challenge.

Gabay M.

Hosp Pharm. 2015 Apr;50(4):259-60. doi: 10.1310/hpj5004-259. Epub 2015 Apr 8. No abstract available.

29.

Prescription Drug Monitoring Programs.

Gabay M.

Hosp Pharm. 2015 Apr;50(4):277-8. doi: 10.1310/hpj5004-277. Epub 2015 Apr 8. No abstract available.

30.

Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.

Álvarez G, Martínez J, Varela J, Birriel E, Cruces E, Gabay M, Leal SM, Escobar P, Aguirre-López B, Cabrera N, Tuena de Gómez-Puyou M, Gómez Puyou A, Pérez-Montfort R, Yaluff G, Torres S, Serna E, Vera de Bilbao N, González M, Cerecetto H.

Eur J Med Chem. 2015 Jul 15;100:246-56. doi: 10.1016/j.ejmech.2015.06.018. Epub 2015 Jun 12.

PMID:
26094151
31.

MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism.

Shroff EH, Eberlin LS, Dang VM, Gouw AM, Gabay M, Adam SJ, Bellovin DI, Tran PT, Philbrick WM, Garcia-Ocana A, Casey SC, Li Y, Dang CV, Zare RN, Felsher DW.

Proc Natl Acad Sci U S A. 2015 May 26;112(21):6539-44. doi: 10.1073/pnas.1507228112. Epub 2015 May 11.

32.

ASHP guidelines on the pharmacist's role in providing drug information.

Ghaibi S, Ipema H, Gabay M; American Society of Health System Pharmacists.

Am J Health Syst Pharm. 2015 Apr 1;72(7):573-7. doi: 10.2146/sp150002. No abstract available.

PMID:
25788512
33.

Identification of a new amide-containing thiazole as a drug candidate for treatment of Chagas' disease.

Álvarez G, Varela J, Cruces E, Fernández M, Gabay M, Leal SM, Escobar P, Sanabria L, Serna E, Torres S, Figueredo Thiel SJ, Yaluff G, Vera de Bilbao NI, Cerecetto H, González M.

Antimicrob Agents Chemother. 2015 Mar;59(3):1398-404. doi: 10.1128/AAC.03814-14. Epub 2014 Dec 15.

34.

Anaerobic metabolism of the agro-pesticide nitroxinil by bovine ruminal fluid.

Irazoqui I, Rodriguez A, Birriel E, Gabay M, Lavaggi ML, Repetto JL, Cajarville C, Gonzalez M, Cerecetto H.

Drug Metab Lett. 2014;8(2):101-8.

PMID:
25496284
35.

USP <800> : Handling Hazardous Drugs.

Gabay M.

Hosp Pharm. 2014 Oct;49(9):811-2. doi: 10.1310/hpj4909-811. No abstract available.

36.

The drug quality and security act.

Gabay M.

Hosp Pharm. 2014 Jul;49(7):615-76. doi: 10.1310/hpj4907-615. No abstract available.

37.

Analyzing temozolomide medication errors: potentially fatal.

Letarte N, Gabay MP, Bressler LR, Long KE, Stachnik JM, Villano JL.

J Neurooncol. 2014 Oct;120(1):111-5. doi: 10.1007/s11060-014-1523-1. Epub 2014 Jul 16.

38.

Alteration of the lipid profile in lymphomas induced by MYC overexpression.

Eberlin LS, Gabay M, Fan AC, Gouw AM, Tibshirani RJ, Felsher DW, Zare RN.

Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10450-5. doi: 10.1073/pnas.1409778111. Epub 2014 Jul 3.

39.

A step forward: review of the new california provider status law.

Gabay M.

Hosp Pharm. 2014 May;49(5):435-6. doi: 10.1310/hpj4905-435. No abstract available.

40.

Transition-metal oxides: It takes two to waver.

Gabay M, Triscone JM.

Nat Nanotechnol. 2014 Jun;9(6):417-8. doi: 10.1038/nnano.2014.108. No abstract available.

PMID:
24894478
41.

MYC activation is a hallmark of cancer initiation and maintenance.

Gabay M, Li Y, Felsher DW.

Cold Spring Harb Perspect Med. 2014 Jun 2;4(6). pii: a014241. doi: 10.1101/cshperspect.a014241. Review.

42.

Mutagenicity of N-oxide containing heterocycles and related compounds: experimental and theoretical studies.

Gabay M, Cabrera M, Maio RD, Paez JA, Campillo N, Lavaggi ML, Cerecetto H, González M.

Curr Top Med Chem. 2014;14(11):1374-87.

PMID:
24805062
43.

Optimization of antitrypanosomatid agents: identification of nonmutagenic drug candidates with in vivo activity.

Álvarez G, Varela J, Márquez P, Gabay M, Arias Rivas CE, Cuchilla K, Echeverría GA, Piro OE, Chorilli M, Leal SM, Escobar P, Serna E, Torres S, Yaluff G, Vera de Bilbao NI, González M, Cerecetto H.

J Med Chem. 2014 May 22;57(10):3984-99. doi: 10.1021/jm500018m. Epub 2014 May 2.

PMID:
24749923
44.

Federal controlled substances act: dispensing requirements, electronic prescriptions, and fraudulent prescriptions.

Gabay M.

Hosp Pharm. 2014 Mar;49(3):244-6. doi: 10.1310/hpj4903-244. No abstract available.

45.

Federal controlled substances act: ordering and recordkeeping.

Gabay M.

Hosp Pharm. 2013 Dec;48(11):919-21. doi: 10.1310/hpj4811-919. No abstract available.

46.

Federal controlled substances act: controlled substances prescriptions.

Gabay M.

Hosp Pharm. 2013 Sep;48(8):644-5. doi: 10.1310/hpj4808-644. No abstract available.

47.

The federal controlled substances act: schedules and pharmacy registration.

Gabay M.

Hosp Pharm. 2013 Jun;48(6):473-4. doi: 10.1310/hpj4806-473. No abstract available.

48.

Expanding the definition of nonprescription drugs: potential impact on pharmacists.

Gabay M.

Hosp Pharm. 2013 Mar;48(3):198-9. doi: 10.1310/hpj4803-198. No abstract available.

49.

Two-dimensional electron gas with six-fold symmetry at the (111) surface of KTaO3.

Bareille C, Fortuna F, Rödel TC, Bertran F, Gabay M, Cubelos OH, Taleb-Ibrahimi A, Le Fèvre P, Bibes M, Barthélémy A, Maroutian T, Lecoeur P, Rozenberg MJ, Santander-Syro AF.

Sci Rep. 2014 Jan 7;4:3586. doi: 10.1038/srep03586.

50.

An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis.

Gabay M, Boucher BA.

Pharmacotherapy. 2013 Sep;33(9):935-55. doi: 10.1002/phar.1291. Epub 2013 May 17. Review.

PMID:
23686938

Supplemental Content

Support Center